
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Fasoracetam is a synthetic racetam nootropic that enhances cognitive function by modulating AMPA receptors and metabotropic glutamate receptors (mGluR). It influences GABA and glutamate neurotransmitter systems to improve memory, learning, and attention while potentially reducing ADHD symptoms.

Reported Benefits (Provisional)
Origin & History

Fasoracetam is a synthetic compound belonging to the racetam family, originally developed in Japan as a treatment for vascular dementia. It is produced through a series of chemical reactions that modify the pyrrolidone nucleus, characteristic of racetams.
Research Narrative (Provisional)
Fasoracetam has been studied in animal models and small human trials, showing promise in cognitive enhancement and ADHD symptom reduction. Further large-scale RCTs are needed to confirm these effects.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Synthetic compound with no caloric or macronutrient content. - Primarily acts on neurotransmitter systems rather than providing nutritional value. - Interacts with glutamate, GABA, and acetylcholine pathways.
Reported Mechanism (Provisional)
Fasoracetam acts as a positive allosteric modulator of AMPA receptors and metabotropic glutamate receptors, particularly mGluR1 and mGluR5. It enhances glutamatergic transmission while modulating GABAergic activity through upregulation of GABA-B receptors. The compound also influences the cholinergic system by increasing acetylcholine release in the hippocampus.
Clinical Narrative (Provisional)
Human clinical trials on fasoracetam remain limited, with most evidence from small-scale studies on ADHD populations. One phase II trial examined 30 adolescents with ADHD and glutamatergic gene mutations, showing modest improvements in attention scores. Animal studies demonstrate enhanced learning and memory formation, but human cognitive enhancement data is primarily anecdotal. Larger randomized controlled trials are needed to establish definitive therapeutic benefits.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







